6-Chlorooxindole CAS 56341-37-8 Purity >99.0% Ziprasidone Hydrochloride Intermediate Factory

Short Description:

Chemical Name: 6-Chlorooxindole

CAS: 56341-37-8

Purity (LCMS): >99.0% 

Appearance: Off-White to Light Brown Crystalline Powder 

Intermediate of Ziprasidone Hydrochloride (CAS: 138982-67-9)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 6-Chlorooxindole (CAS: 56341-37-8) with high quality, commercial production. Welcomed to order.

Chemical Properties:

Chemical Name 6-Chlorooxindole
Synonyms 6-Chloro-2-Oxoindole; 6-Chloro-2-Indolinone; 6-Chloro-1,3-Dihydro-indole 2-one; 6-Chloro-1,3-Dihydroindole-2-one
CAS Number 56341-37-8
CAT Number RF-PI1611
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C8H6ClNO
Molecular Weight 167.59 
Density 1.362±0.06 g/cm3
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Off-White to Light Brown Crystalline Powder
1 H NMR Spectrum Consistent With Structure
LCMS Consistent With Structure
Purity (LCMS) >99.0%
Melting Point 195.0~199.0℃
Loss on Drying <1.00%
Total Impurities <1.00%
Test Standard Enterprise Standard
Usage Intermediate of Ziprasidone Hydrochloride (CAS: 138982-67-9)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

1

FAQ:

Application:

6-Chlorooxindole (CAS: 56341-37-8) is an intermediate of Ziprasidone Hydrochloride (CAS: 138982-67-9). Ziprasidone Hydrochloride is the hydrochloride salt of a benzisothiazolylpiperazine analog structurally related to the atypical antipsychotic drug tiospirone that antagonizes both central serotonin 5-HT2A (Ki = 0.42 nM) and dopamine D2 (Ki = 4.8 nM) receptors.  It is also a potent agonist at 5-HT1A receptors (Ki = 3.4 nM), increasing cortical dopamine release which may offset negative effects associated with dopamine D2 antagonism, and an inverse agonist at 5-HT1B and 5-HT1D receptors (pKis = 8.8 and 8.6, respectively). 

  • Write your message here and send it to us